Results of thoracic endovascular grafting in different aortic segments

Germano Melissano1, Luca Bertoglio, Efrem Civilini

  • 1Department of Vascular Surgery, Vita - Salute University, Scientific Institute H. San Raffaele, Milan, Italy. g.melissano@hsr.it

Insights

Thoracic endovascular grafting shows favorable results for aortic arch and descending thoracic aorta (DTA) pathologies. Hybrid procedures enable treatment of all aortic segments but reduce success rates, especially for thoracoabdominal aorta (TaA) cases.

Area of Science:

  • Vascular Surgery
  • Endovascular Interventions
  • Aortic Disease Management

Background:

  • Thoracic endovascular aortic repair (TEVAR) has evolved for treating various aortic pathologies.
  • Commercially available stent-grafts offer options for complex aortic repairs.
  • Hybrid procedures combine endovascular and open surgical techniques.

Purpose of the Study:

  • To compare outcomes of thoracic endovascular grafting across different aortic segments.
  • To evaluate the efficacy of commercially available stent-grafts in TEVAR.
  • To assess the impact of hybrid procedures on TEVAR success rates.

Main Methods:

  • Retrospective analysis of 178 patients undergoing TEVAR between 1999 and 2006.
  • Patients categorized into aortic arch, descending thoracic aorta (DTA), and thoracoabdominal aorta (TaA) groups.
  • Inclusion of hybrid procedures for supra-aortic trunk revascularization, access, or associated abdominal aortic aneurysms.

Main Results:

  • Overall technical success rate of 93.8% with 5.6% 30-day mortality.
  • Descending thoracic aorta (DTA) group showed highest technical success (98.0%) and lowest mortality (2.0%).
  • Aortic arch and thoracoabdominal aorta (TaA) groups had higher complication rates and lower initial/midterm success, particularly TaA (28.6% 30-day mortality).

Conclusions:

  • Endovascular grafting is effective for DTA and aortic arch pathologies.
  • Hybrid procedures facilitate treatment of all aortic segments but may decrease success rates.
  • Stent-graft use for thoracoabdominal aorta (TaA) should be reserved for high-risk or compassionate cases.
Abstract